These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31980565)

  • 1. Impacts of genomics on the health and social costs of intellectual disability.
    Doble B; Schofield D; Evans CA; Groza T; Mattick JS; Field M; Roscioli T
    J Med Genet; 2020 Jul; 57(7):479-486. PubMed ID: 31980565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing in intellectual disability; cost before and after a diagnosis.
    Vrijenhoek T; Middelburg EM; Monroe GR; van Gassen KLI; Geenen JW; Hövels AM; Knoers NV; van Amstel HKP; Frederix GWJ
    Eur J Hum Genet; 2018 Nov; 26(11):1566-1571. PubMed ID: 29959382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic yield of intellectual disability: combined whole genome low-coverage sequencing and medical exome sequencing.
    Wang J; Wang Y; Wang L; Chen WY; Sheng M
    BMC Med Genomics; 2020 May; 13(1):70. PubMed ID: 32429945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
    Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
    Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability.
    Monroe GR; Frederix GW; Savelberg SM; de Vries TI; Duran KJ; van der Smagt JJ; Terhal PA; van Hasselt PM; Kroes HY; Verhoeven-Duif NM; Nijman IJ; Carbo EC; van Gassen KL; Knoers NV; Hövels AM; van Haelst MM; Visser G; van Haaften G
    Genet Med; 2016 Sep; 18(9):949-56. PubMed ID: 26845106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Societal cost of childhood intellectual disability in Australia.
    Arora S; Goodall S; Viney R; Einfeld S
    J Intellect Disabil Res; 2020 Jul; 64(7):524-537. PubMed ID: 32329168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much does intellectual disability really cost? First estimates for Australia.
    Doran CM; Einfeld SL; Madden RH; Otim M; Horstead SK; Ellis LA; Emerson E
    J Intellect Dev Disabil; 2012 Mar; 37(1):42-9. PubMed ID: 22339044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost trajectory of the diagnostic care pathway for children with suspected genetic disorders.
    Dragojlovic N; van Karnebeek CDM; Ghani A; Genereaux D; Kim E; Birch P; ; Elliott AM; Friedman JM; Lynd LD
    Genet Med; 2020 Feb; 22(2):292-300. PubMed ID: 31462755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient genetic test flow for multiple congenital anomalies and intellectual disability.
    Yokoi T; Enomoto Y; Tsurusaki Y; Harada N; Saito T; Nagai JI; Naruto T; Kurosawa K
    Pediatr Int; 2020 May; 62(5):556-561. PubMed ID: 31955471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic cost of autism in the UK.
    Knapp M; Romeo R; Beecham J
    Autism; 2009 May; 13(3):317-36. PubMed ID: 19369391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the costs of epilepsy in adults with an intellectual disability.
    Pennington M; Prince E; Bateman N; Gray J; Croudace TJ; Redley M; Wood N; Ring H
    Seizure; 2012 Apr; 21(3):205-10. PubMed ID: 22285238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).
    Manickam K; McClain MR; Demmer LA; Biswas S; Kearney HM; Malinowski J; Massingham LJ; Miller D; Yu TW; Hisama FM;
    Genet Med; 2021 Nov; 23(11):2029-2037. PubMed ID: 34211152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic exome sequencing in 100 consecutive patients with both epilepsy and intellectual disability.
    Snoeijen-Schouwenaars FM; van Ool JS; Verhoeven JS; van Mierlo P; Braakman HMH; Smeets EE; Nicolai J; Schoots J; Teunissen MWA; Rouhl RPW; Tan IY; Yntema HG; Brunner HG; Pfundt R; Stegmann AP; Kamsteeg EJ; Schelhaas HJ; Willemsen MH
    Epilepsia; 2019 Jan; 60(1):155-164. PubMed ID: 30525188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High health care costs among adults with intellectual and developmental disabilities: a population-based study.
    Lunsky Y; De Oliveira C; Wilton A; Wodchis W
    J Intellect Disabil Res; 2019 Feb; 63(2):124-137. PubMed ID: 30381849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering Intellectual Disability.
    Gupta N
    Indian J Pediatr; 2023 Feb; 90(2):160-167. PubMed ID: 36441387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of intellectual disability and autism comorbidity through gene panel sequencing.
    Aspromonte MC; Bellini M; Gasparini A; Carraro M; Bettella E; Polli R; Cesca F; Bigoni S; Boni S; Carlet O; Negrin S; Mammi I; Milani D; Peron A; Sartori S; Toldo I; Soli F; Turolla L; Stanzial F; Benedicenti F; Marino-Buslje C; Tosatto SCE; Murgia A; Leonardi E
    Hum Mutat; 2019 Sep; 40(9):1346-1363. PubMed ID: 31209962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield.
    Anazi S; Maddirevula S; Faqeih E; Alsedairy H; Alzahrani F; Shamseldin HE; Patel N; Hashem M; Ibrahim N; Abdulwahab F; Ewida N; Alsaif HS; Al Sharif H; Alamoudi W; Kentab A; Bashiri FA; Alnaser M; AlWadei AH; Alfadhel M; Eyaid W; Hashem A; Al Asmari A; Saleh MM; AlSaman A; Alhasan KA; Alsughayir M; Al Shammari M; Mahmoud A; Al-Hassnan ZN; Al-Husain M; Osama Khalil R; Abd El Meguid N; Masri A; Ali R; Ben-Omran T; El Fishway P; Hashish A; Ercan Sencicek A; State M; Alazami AM; Salih MA; Altassan N; Arold ST; Abouelhoda M; Wakil SM; Monies D; Shaheen R; Alkuraya FS
    Mol Psychiatry; 2017 Apr; 22(4):615-624. PubMed ID: 27431290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic yield of patients with undiagnosed intellectual disability, global developmental delay and multiples congenital anomalies using karyotype, microarray analysis, whole exome sequencing from Central Brazil.
    Leite AJDC; Pinto IP; Leijsten N; Ruiterkamp-Versteeg M; Pfundt R; de Leeuw N; da Cruz AD; Minasi LB
    PLoS One; 2022; 17(4):e0266493. PubMed ID: 35390071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare costs of intellectual disability in the Netherlands: a cost-of-illness perspective.
    Polder JJ; Meerding WJ; Bonneux L; van der Maas PJ
    J Intellect Disabil Res; 2002 Feb; 46(Pt 2):168-78. PubMed ID: 11869388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-based recruitment and exome sequencing indicates high diagnostic yield in adults with intellectual disability.
    Sabo A; Murdock D; Dugan S; Meng Q; Gingras MC; Hu J; Muzny D; Gibbs R
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1439. PubMed ID: 32767738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.